Literature DB >> 12667469

Attenuation of MPTP-induced neurotoxicity and behavioural impairment in NSE-XIAP transgenic mice.

S J Crocker1, P Liston, H Anisman, C J Lee, P D Smith, N Earl, C S Thompson, D S Park, R G Korneluk, G S Robertson.   

Abstract

X-linked IAP protein is a potent inhibitor of cell death. Here, we describe a novel transgenic mouse in which the human XIAP gene is expressed under the control of the neuron-specific enolase promoter (NSE-xiap). We demonstrate that nigrostriatal dopamine neurons of NSE-xiap mice were resistant to the damaging effects of the dopaminergic neurotoxin MPTP. MPTP-induced reduction of striatal dopamine metabolism was also attenuated in NSE-xiap mice. Furthermore, NSE-xiap mice treated with MPTP did not exhibit deficits in exploratory behaviour in an open-field test. Taken together, these findings suggest that strategies to enhance neuronal expression of XIAP may provide therapeutic benefit for the treatment of neurodegeneration in Parkinson's disease. Copyright 2003 Elsevier Science (USA)

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12667469     DOI: 10.1016/s0969-9961(02)00020-7

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  17 in total

Review 1.  Apoptotic cell death regulation in neurons.

Authors:  Emilie Hollville; Selena E Romero; Mohanish Deshmukh
Journal:  FEBS J       Date:  2019-07-12       Impact factor: 5.542

2.  Overexpression of IAP-2 attenuates apoptosis and protects against myocardial ischemia/reperfusion injury in transgenic mice.

Authors:  Chu Chang Chua; Jinping Gao; Ye-Shih Ho; Ye Xiong; Xingshun Xu; Zhongyi Chen; Ronald C Hamdy; Balvin H L Chua
Journal:  Biochim Biophys Acta       Date:  2007-01-25

3.  Perturbation of transcription factor Nur77 expression mediated by myocyte enhancer factor 2D (MEF2D) regulates dopaminergic neuron loss in response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

Authors:  Matthew P Mount; Yi Zhang; Mandana Amini; Steve Callaghan; Jerzy Kulczycki; Zixu Mao; Ruth S Slack; Hymie Anisman; David S Park
Journal:  J Biol Chem       Date:  2013-03-27       Impact factor: 5.157

Review 4.  Programmed cell death in Parkinson's disease.

Authors:  Katerina Venderova; David S Park
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

5.  The crucial role of caspase-9 in the disease progression of a transgenic ALS mouse model.

Authors:  Haruhisa Inoue; Kayoko Tsukita; Takuji Iwasato; Yasuyuki Suzuki; Masanori Tomioka; Minako Tateno; Masahiro Nagao; Akihiro Kawata; Takaomi C Saido; Masayuki Miura; Hidemi Misawa; Shigeyoshi Itohara; Ryosuke Takahashi
Journal:  EMBO J       Date:  2003-12-15       Impact factor: 11.598

6.  S-nitrosylation of XIAP compromises neuronal survival in Parkinson's disease.

Authors:  Anthony H K Tsang; Yun-Il Lee; Han Seok Ko; Joseph M Savitt; Olga Pletnikova; Juan C Troncoso; Valina L Dawson; Ted M Dawson; Kenny K K Chung
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-09       Impact factor: 11.205

7.  Targeting Cdk5 activity in neuronal degeneration and regeneration.

Authors:  Jyotshnabala Kanungo; Ya-li Zheng; Niranjana D Amin; Harish C Pant
Journal:  Cell Mol Neurobiol       Date:  2009-12       Impact factor: 5.046

8.  Noninvasive in vivo monitoring of neuronal differentiation using reporter driven by a neuronal promoter.

Authors:  Do Won Hwang; Joo Hyun Kang; Jae Min Jeong; June-Key Chung; Myung Chul Lee; Soonhag Kim; Dong Soo Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-09-21       Impact factor: 9.236

9.  MPTP intoxication in mice: a useful model of Leigh syndrome to study mitochondrial diseases in childhood.

Authors:  E Lagrue; B Abert; L Nadal; L Tabone; S Bodard; F Medja; A Lombes; S Chalon; P Castelnau
Journal:  Metab Brain Dis       Date:  2009-03-25       Impact factor: 3.584

10.  XIAP effects on retinal detachment-induced photoreceptor apoptosis [corrected].

Authors:  Laura A Zadro-Lamoureux; David N Zacks; Adam N Baker; Qiong-Duan Zheng; William W Hauswirth; Catherine Tsilfidis
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-12-05       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.